IGIgor Z. Gladchuk

Igor Z. Gladchuk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Igor Z. Gladchuk has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and anamnestic characteristics of infertile patients with ovarian endometriomas in assisted reproductive technology programs

    by A.V. Volyanyuk, I.Z. Gladchuk, N.M. Rozhkovska, G.L. Lavrynenko, V.I. Gladchuk

    Objective of the study: to evaluate the clinical, anamnestic, reproductive, and hormonal characteristics of infertile patients with ovarian endometriomas depending on prior surgical treatment in assisted reproductive technology.Materials and methods. A retrospective cohort study was conducted involving 67 infertile patients who underwent evaluation and treatment using assisted reproductive technology programs between 2024 and 2026. Group 1 included 24 patients with ovarian endometriomas following surgical treatment; Group 2 included 23 patients with untreated ovarian endometriomas; and Group 3, the control group, included 20 patients with male-factor and/or absolute tubal infertility without endometriosis. Results. No statistically significant differences in age were found between the groups. At the same time, the groups differed in body mass index, age at menarche, and duration of infertility. Primary infertility was more common in patients with ovarian endometriomas, whereas secondary infertility predominated in the control group. Patients with endometriomas typically presented with dysmenorrhea and pre- and postmenstrual bleeding. The highest incidence of dysmenorrhea was observed in the group with untreated endometriomas. Regarding hormonal profile indicators, statistically significant differences were found in the levels of anti-Müllerian hormone and estradiol. The lowest anti-Müllerian hormone level was found in patients with endometriomas (0.61 ± 0.07 ng/mL), whereas in patients who had undergone surgical treatment it was 1.67 ± 0.28 ng/mL, and in the control group – 1.38 ± 0.14 ng/mL. Estradiol levels were highest in Group 2 – 143.5 ± 40.1 pg/mL. Conclusions. Infertile patients with ovarian endometriomas exhibit characteristic clinical and anamnestic features, including a higher prevalence of primary infertility, dysmenorrhea, and menstrual cycle disorders. The presence of untreated ovarian endometriomas was associated with a statistically significant decrease in anti-Müllerian hormone levels and an increase in estradiol levels. The results confirm the need for an individualized assessment of reproductive potential and ovarian reserve when planning assisted reproductive technology in patients with ovarian endometriomas.

  • Open Access

    Cytomorphological criteria for the differential diagnosis of endometrial hyperplasia and endometrial cancer

    by V.O. Sytnikova, S.O. Bashtan, I.Z. Gladchuk, N.M. Rozhkovska

    Objective of the study: to establish an optimal set of cytological criteria and to develop a mathematical algorithm to improve the effectiveness of the differential diagnosis of endometrial hyperplasia and cancer.Materials and methods. A preoperative examination of the endometrium was carried out in 32 patients with abnormal uterine bleeding by means of aspiration cytology, using a standardized assessment algorithm comprising 7 most informative cytomorphological features. Based on mathematical analysis and Bayes’ theorem, an expert diagnostic system was developed, defining weighting coefficients and threshold values for differentiating between endometrial hyperplasia and endometrial cancer. The cytology findings were verified by the results of the post-operative histological examination.Results. The comprehensive use of standardized cytological criteria in combination with a mathematical algorithm improves the accuracy of the differential diagnosis of hyperplastic and malignant processes of the endometrium. The most significant cytological criteria for differential diagnosis were found to be impaired cell polarity within structures, an increased nuclear-cytoplasmic index, abnormal nuclear and nucleolar shapes, irregular nuclear membranes, neoplastic features and the formation of three-dimensional cell structures. In the group of women aged 30–39 years, a low prevalence of endometrial cancer was confirmed. The summary coefficient did not reach the threshold level. In the 40–49 age group, an increase in the frequency of endometrial hyperplastic processes, polyps and abnormal uterine bleeding was observed. It was in this group that the first case of endometrial carcinoma was recorded. In the patient with a malignant endometrial tumor, the summary diagnostic coefficient significantly exceeded the threshold value (+195), indicating the presence of a complex of cytomorphological features characteristic of malignant transformation of the endometrium. In women aged 60–69 years, endometrial pathology was represented by both glandular hyperplasia and endometrial cancer. The total diagnostic coefficient significantly exceeded the established diagnostic threshold.Conclusions. The results obtained support the comprehensive use of cytological criteria and a mathematical algorithm for differential diagnosis, which helps to improve the accuracy of detecting precancerous and malignant changes in the endometrium and may be recommended for implementation in cytology laboratories and clinical settings.

  • Open Access

    Features of laparoscopic ICG mapping of sentinel lymph nodes in early endometrial cancer in patients with obesity

    by I.Z. Gladchuk, D.A. Kiriakova, O.YE. Sidac, O.S. Herasymenko, V.M. Zaporozhan

    Background. Endometrial cancer ranks among the most common malignant tumors of the female reproductive system. In modern gynecologic oncology, sentinel lymph node mapping is increasingly used as an alternative to systemic pelvic lympha-denectomy. Obesity is a common comorbid condition in patients with endometrial cancer, occurring in at least 60% of patients.Purpose – to evaluate sentinel lymph node detection in patients with early-stage endometrial cancer using indocyanine green guided near-infrared fluorescence laparoscopy, with particular emphasis on obese patients, to optimize the effectiveness of the procedure.Materials and Methods. A retrospective cohort study was conducted at the Department of Gynecology of the Multidisciplinary Medical Center, Odesa National Medical University, between 2018 and 2025. The study included 80 patients with low- and intermediate-risk endometrial cancer who underwent laparoscopic hysterectomy with bilateral salpingo-oophorectomy and sentinel lymph node biopsy using submucosal intracervical injection of indocyanine green. Patients were stratified into two groups according to body mass index: <30 kg/m2 and ≥30 kg/m2.Results. Failure to identify sentinel lymph nodes was significantly more frequent in obese patients than in non-obese patients (35.5% vs. 10.3%; p = 0.017), resulting in a 26% reduction in the overall mapping success rate. Bilateral sentinel lymph node detection was achieved in 50.5% of obese patients compared with 60.2% of those with a BMI <30 kg/m2. Operative time was significantly longer in the obese group (108.0 ± 11.6 vs. 88.5 ± 8.8 min; p < 0.001). The use of partial retroperitoneal dissection increased the mapping success rate from 56.0% to 72.0%, corresponding to an absolute improvement of 16%. The optimal indocyanine green exposure interval was 15–25 minutes (p = 0.62).Conclusions. A high body mass index (≥30) is associated with a 26% decrease in the success rate of sentinel lymph node biopsy; however, it does not preclude the possibility of successful mapping. The use of additional technical techniques can increase the rate of indocyanine green uptake by 16%. One of the key factors for successful mapping is adherence to the optimal exposure time for indocyanine green (15–25 min), especially in obese patients and those who have undergone abdominal surgery.

  • Open Access

    INSTITUTIONAL EXPERIENCE WITH LAPAROSCOPIC ANTERIOR VAGINOCERVICOPEXY USING A MESH IMPLANT IN PATIENTS WITH ANTERIOR COMPARTMENT DEFECT AND APICAL PROLAPSE OF VARYING SEVERITY

    by Yurii O. Chekhanov, Oleksandr Yu. Chekhanov, Igor Z. Gladchuk

    Introduction. In reconstructive pelvic floor surgery using synthetic implants, several laparoscopic techniques have evolved as alternatives to sacrocolpopexy. Laparoscopic vaginocervicopexy is intended to correct apical descent together with anterior compartment failure. Since its first publication, the technique has been repeatedly modified, emphasizing the need to evaluate outcomes of different technical refinements across clinical scenarios. The aim of this study was to report a single-center experience with a modified laparoscopic vaginocervicopexy technique and to assess its effectiveness in relation to defect location and severity. Methods. Outcomes of 137 women with apical and combined prolapse (apical defect with cystocele), including women with a preserved uterus and women after hysterectomy, operated on in 2018–2024 were analyzed. The modification included intraoperative individualization of mesh dimensions based on measured dissection length and width, followed by bilateral fixation to the aponeurosis of the anterior abdominal wall. The assessment included intraoperative and postoperative complications, recurrences, repeat surgeries, operative time, length of hospital stay, and patient-reported satisfaction measured with a standardized satisfaction questionnaire using a five-point response scale. Mean follow-up was 12.8 months. Results. Mean age at surgery was 61.56 ± 9.59 years. The complication rate was 1.46 %, and the recurrence rate was 3.65 %. Mean operative time was 90.36 ± 14.33 minutes, and mean hospitalization duration was 52.20 ± 6.27 hours. Intraoperative blood loss did not exceed 150 mL. Patient-reported satisfaction was high, with a mean score of 4.54 ± 0.41 points, without meaningful differences across clinical groups. Discussion. The modified laparoscopic vaginocervicopexy with individualized mesh sizing and bilateral fixation to the anterior abdominal wall aponeurosis demonstrated favorable mid-term outcomes, combining high effectiveness with low complication and recurrence rates in women with apical prolapse and cystocele.

  • Open Access

    Bowel endometriosis in clinical practice: analysis of localizations and associations with other forms and subtypes of endometriosis according to #ENZIAN (2021)

    by Yu.S. Ocheretna, O.I. Shevchenko, H.V. Shytova, I.Z. Hladchuk

    Bowel endometriosis (BE) is one of the most severe manifestations of deep infiltrating endometriosis. The current literature provides limited data regarding its prevalence, anatomical localization, and associations with other forms of endometriosis. Understanding these features is important for improving diagnosis and treatment planning.The objective: to analyze the frequency, anatomical localizations, and forms of BE, as well as its associations with other forms and subtypes of endometriosis according to the #ENZIAN (2021) classification.Materials and methods. A retrospective analysis of 420 medical records of patients who underwent laparoscopic surgery for endometriosis at the University Clinic of Odesa National Medical University in 2019–2023 was conducted. 135 patients with BE were selected for further analysis. The anatomical characteristics of lesions and their associations with other forms of endometriosis were evaluated according to the #ENZIAN (2021) classification.Results. BE was identified in 135 (32.1%) patients who underwent surgery for endometriosis. The most common localizations were the rectosigmoid junction (45.9%) and the rectum (37.8%) – compartment C #ENZIAN. Involvement of compartment FI #ENZIAN was observed in 24.4% of patients: the sigmoid colon – in 14.1%, appendix and cecum – 3.7% each, colon – 2.2%, small intestine – 0.7%. Multifocal lesions were detected in 30.4% of cases, multicentric lesions – in 8.1%. BE most frequently coexisted with peritoneal endometriosis (compartment P) – 90.4%, involvement of the uterosacral ligaments and lateral pelvic wall (compartment B) – 80.0%, and ovarian endometriosis (compartment O) – 79.2%. Isolated BE was found in 3.7% of cases. Adhesions were present in 94.8% of patients.Conclusions. BE is present in one-third of patients with laparoscopically confirmed endometriosis and most commonly involves the rectosigmoid segment and rectum (compartment C #ENZIAN). In the majority of cases, it is associated with other forms of endometriosis and accompanied by significant adhesions.

  • Open Access

    Features of assessing the condition of pregnant women with parathyroid adenoma

    by V.P. Mishchenko, I.Z. Gladchuk, V.V. Mishchenko

    The relevance of this topic lies in the lack of reliable statistical data in available literature regarding the incidence of parathyroid gland disorders in pregnant women and the differences in diagnosis and therapy during pregnancy versus outside of pregnancy. A physician’s knowledge of the physiological changes that occur in a woman’s body during pregnancy, including mineral metabolism and endocrine gland function, facilitates accurate and timely differential diagnosis between parathyroid tumors, physiological processes, and symptoms of gestational complications. Differential diagnosis of parathyroid pathology from gestational processes at various stages of pregnancy is complex. Timely detection of parathyroid pathology is particularly important at the stage of pregnancy planning. Differential diagnosis of parathyroid adenoma is carried out in comparison with gestational processes, including gestational complications such as nausea and vomiting in pregnant women. Late diagnosis of clinical manifestations of parathyroid pathology in pregnancy can lead to severe consequences for both the mother and the fetus. For this reason, in clinical practice, timely detection of parathyroid pathology during the pregnancy planning stage is essential. Examination of pregnant women and determination of therapeutic interventions should be multidisciplinary, personalized, and include measurement of blood levels of thyroid-stimulating hormone, vitamin D, calcium, magnesium, phosphorus, and parathyroid hormone. Therapeutic options for hyperparathyroidism in pregnant women are limited. A personalized and multidisciplinary approach is essential in each individual case. Women with parathyroid tumors require individualized, qualified monitoring during both the early and late postpartum periods and during lactation, as there is always a risk of hypercalcemia. Administration of vitamin D should be carried out under laboratory control of its blood levels in pregnant women and should be personalized, taking into account the gestational age. In newborns of mothers with parathyroid tumors, it is necessary to monitor calcium levels in both blood and urine.

  • Open Access

    The symptom-modifying effect of dienogest in patients with genital endometriosis who have proliferative changes in the mammary glands

    by A.S. Lunko, A.G. Volyanska, I.Z. Gladchuk

    Modern studies show that in different countries 15–70% of patients with genital endometriosis (GE) have concomitant breast pathology, which is considered a manifestation of overlap syndrome. This category of patients requires a detailed examination of the mammary glands when choosing hormonal therapy, as well as more careful observation during treatment.The objective: to assess the symptom-modifying effect of dienogest in patients with GE who have proliferative changes in the mammary glands.Materials and methods. 226 women of reproductive age with GE were examined. Staging of endometriosis was performed according to the revised version of the American Society of Reproductive Medicine classification after laparoscopic intervention. Diagnosis, treatment and clinical monitoring of patients were carried out in compliance with modern bioethical requirements, as well as in accordance with the recommendations of the World Health Organization and the American College of Obstetricians and Gynecologists. All patients had ultrasound examination of the mammary glands. Changes in functional status were assessed using the Breast imaging reporting and data system (BI-RADS) scale. Endopain questionnaire was used to determine the intensity of pain syndrome in GE. As a symptom-modifying drug, patients were prescribed dienogest 2 mg once a day for 24 weeks. The presence of clinical manifestations of GE was determined before and after treatment.Results. Proliferative changes in the tissues of the mammary gland were detected in 65.6% of the examined patients with GE. As the stage of endometriosis progresses, the severity of proliferative changes in the mammary glands increases (positive correlation of medium strength with the stage of external GE was found, r = 0.53; p < 0.05). In the selected cohort of patients, the use of dienogest 2 mg for 6 months led to a decrease in the intensity, and in many cases to the disappearance of chronic pelvic pain syndrome and other manifestations of the disease: algodysmenorrhea and dyspareunia.Conclusions. The study confirmed the world data that the overlap syndrome of GE and dyshormonal breast diseases is a common clinical phenomenon. It has been established that with increasing stage of endometriosis, there is an increase in the breast pathologies frequency. In the treatment of patients with overlap syndrome of GE and dyshormonal breast diseases, the effectiveness of dienogest has been confirmed, as evidenced by the regression of clinical symptoms of GE, in particular, a decrease in the intensity of chronic pelvic pain syndrome. It is important that hormonal therapy for endometriosis has demonstrated a high safety profile, because it not only does not provoke the occurrence of side effects, but also does not have an undesirable effect on the functional state of the mammary glands.

  • Open Access

    The effectiveness of iron deficiency nutritional correction in patients with genital endometriosis accompanied by mild anemia

    by I.Z. Gladchuk, A.G. Volyanska, A.S. Lunko, T.A. Lunko

    Background. Women with endometriosis are at higher risk of developing iron deficiency than those without endomet­riosis. The results of many studies indicate that iron deficiency should be considered during the initial diagnosis and subsequent treatment of endometriosis, since menstrual disorders with the simultaneous presence of endometrioid heterotopias are one of the factors for the development of anemia in women. The purpose was to study the effectiveness of nutritional correction of iron deficiency in patients with genital endometriosis accompanied by dysmenorrhea. Materials and methods. Endometriosis patients with mild anemia were prescribed nutritional correction of iron deficiency. In the study group (n = 34), women received a complex of microencapsulated iron pyrophosphate (14 mg) in liposomal form with folic acid (200 μg), vitamin B12 (2.5 μg) and vitamin C (80 mg), as well as a dietary supplement of lactoferrin at a dose of 250 mg per day for 2 months; in the comparison group (n = 32), the above-mentioned combination drug was administered without adding lactoferrin to the diet. The patients were assessed for the following indicators: hemoglobin level, erythrocyte count, ferritin levels, transferrin and total serum iron concentration before treatment and after 2 months. Results. Nutritional correction of iron deficiency in patients with endometriosis accompanied by mild anemia with the use of a complex of iron pyrophosphate and vitamins is not only effective, but also safe, because no side effects of diet therapy were recorded. Adding the dietary supplement lactoferrin to the iron-vitamin preparation improves restoration of the iron metabolism level and normalizes its key indicators: hemoglobin, ferritin and serum iron, and leads to a more significant increase in transferrin. It is also important that the mean corpuscular hemoglobin concentration in the study group reached normal, while in the comparison group, it only approached normal values. Conclusions. Lactoferrin in combination with an iron-vitamin complex can provide the most favorable conditions for the absorption of the required amount of iron against the background of a decrease in the inflammation and normalization of the microbiota. Due to its affinity for transferrin, lactoferrin participates in the full restoration of the proper level of iron metabolism, which is consistent with the data of other studies in recent years.


  • Open Access

    Endometrial stromal sarcoma: description of a rare clinical case

    by I.Z. Gladchuk, N.M. Rozhkovska, O.S. Saleh, T.O. Savenko

    The rapid growth of uterine leiomyoma and disruption of its nutrition require differentiation from uterine sarcoma, although the incidence of sarcoma is about 1% of all malignant gynecological diseases. After myomectomy or hysterectomy, there is a 0.2–0.5% risk of detecting endometrial stromal sarcoma, and the differential diagnosis of cellular leiomyoma and sarcoma is difficult not only for clinicians but also for pathologists. Given the rarity and complexity of diagnosing endometrial stromal sarcoma, each case is of significant clinical and scientific interest.The article presents a clinical case of endometrial stromal sarcoma in a teenage girl. A 16-year-old female patient consulted her family doctor complaining of a fever of 38–39 °C for several days and general weakness. The examination revealed no changes in the lungs. She had regularly menses since the age of 12, but for the last 3 months her periods had been heavier and longer, leading to moderate anemia. An ultrasound examination, magnetic resonance imaging, and diagnostic laparoscopy at a children’s hospital led to a diagnosis of uterine fibroids. Due to suspected necrosis of the myomatous node, Pfannenstiel laparotomy and conservative myomectomy were performed. In the postoperative period, fever persisted, there was the resistance to anti-inflammatory and antibacterial therapy, as well as leukocytosis and lymphopenia, accompanied by increased levels of inflammation markers and the formation of hematoma and infiltrate in the abdominal cavity. The histological result indicate the low-grade endometrial stromal sarcoma; the material was sent for review and immunohistochemical (IHC) examination, which diagnosed high-grade endometrial stromal sarcoma.Given the histological diagnosis of sarcoma and the development of inflammatory complications, a decision was made to perform a hysterectomy with appendages, a biopsy of the greater omentum, and to change the antibiotic therapy in accordance with the sensitivity of the detected microorganism (Enterococcus faecium). Histological and IHC examinations of the removed uterus with appendages confirmed the presence of low-grade endometrial stromal sarcoma, positive for estrogen and progesterone receptors, with wild-type p53 expression and the presence of inflammatory changes. Positive clinical dynamics were observed in the postoperative period. The patient was discharged in satisfactory condition and referred to the National Cancer Institute of Ministry of Health of Ukraine, where she was consulted by a multidisciplinary team of specialists and diagnosed with low-grade endometrial stromal sarcoma T1N0M0 stage 1, clinical group 2. Megestrol acetate at a dose of 160 mg was prescribed as adjuvant therapy for 2 years. Follow-up computed tomography of the chest, abdomen, and pelvis 3 and 6 months after surgery showed no signs of disease progression.Conclusions. Endometrial stromal sarcoma is a rare malignant uterine tumor that can mimic the clinical picture of leiomyoma, especially in young patients. Differential diagnosis between cellular leiomyoma and uterine sarcoma is difficult even for experienced morphologists, which necessitates the use of IHC methods. The presence of rapid tumor growth and signs of impaired nutrition requires cancer awareness and careful preoperative examination. A multidisciplinary approach of surgical treatment, pathomorphological confirmation, and adjuvant hormonal therapy contributes to the achievement of favorable short-term results.

  • Open Access

    Effectiveness of laparoscopic correction of niche after cesarean section

    by I.Z. Gladchuk, N.M. Rozhkovska, Z.I. Gladchuk, З.і. Гладчук

    The frequency of niche after cesarean section (NACS) is 25–85% and depends on many factors, increasing with each next cesarean section, which can cause chronic abnormal uterine bleeding, pelvic pain, subfertility.The objective: to evaluate the immediate and long-term results of the developed method of laparoscopic correction of symptomatic NACS.Materials and methods. During 2022–2024, 58 patients of reproductive age were prospectively observed in the clinics of the Odesa National Medical University: 28 women (main group) with a NACS and 30 practically healthy women of the same age with a uterine scar who were examined for male factor infertility (control group). A comprehensive assessment of the uterine scar, length, depth, width of the niche, and thickness of the residual myometrium was performed using ultrasound examonation. The histological structure of the endometrium and myometrium was studied. All patients in the main group underwent laparoscopic isthmoplasty using the developed technique (two-row separate Vicryl (2.0) sutures with delayed tying of 1 row of sutures).Results. The niche was visualized by transvaginal ultrasound examination as a defect in the myometrium in the anterior uterine wall of a triangular, oval or irregular shape, with a depth of 6.3 ± 1.6 mm, the thickness of the residual myometrium was from 2 to 4 mm, on average 3.0 ± 0.3 mm. The most frequent symptoms of the NACS were menorrhagia – 35.7%, intermenstrual bleeding – 32.1%, perimenstrual spotting – 67.9%, chronic pelvic pain – 57.1%, dysmenorrhea – 64.3%, dyspareunia – 53.6%, chronic vaginal discharge – 28.6% and subfertility – 53.6% of cases. Laparoscopic isthmoplasty according to the developed technique after 3 months after surgery contributed to a significant reduction in the frequency of menorrhagia by 3.3 times (p < 0.01), intermenstrual bleeding by 3.0 times (p < 0.01), perimenstrual spotting by 3.2 times (p < 0.01), as well as chronic pelvic pain by 2.7 times (p < 0.01), dysmenorrhea by 2.2 times (p < 0.05), dyspareunia by 2.5 times (p < 0.05), chronic vaginal discharge with a stable clinical effect 6 and 12 months after surgery. The thickness of the residual myometrium after laparoscopic isthmoplasty increased from 3.0 ± 0.6 to 4.5 ± 0.4 mm after 3 months, to 5.2 ± 0.6 mm after 6 months and up to 5.9 ± 0.5 mm 12 months after laparoscopic treatment (p < 0.01).Conclusions. Laparoscopic correction of symptomatic NACS using the developed technique helps to reduce symptoms of abnormal uterine bleeding, pelvic pain, increase the thickness of the residual myometrium, and improves the pregnancy rate in patients with subfertility.